Sign in
4

Changes in Ownership

ENDRA Life Sciences Inc. Filed Acc 0001209191-19-060093

Options or other derivatives

  • Chief Financial Officer acquired 148,434.74 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Wells David R. · Chief Financial Officer

Table II: Derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2019-12-11 Grant or award : show line 1 in the form Stock option (right to buy) +138,375 138,375 D
2019-12-11 Grant or award : show line 2 in the form Series A Convertible Preferred Stock +8.74 $1,143.68 $10,000 8.74 D
2019-12-11 Grant or award : show line 3 in the form Warrants +10,051 10,051 D
Loading xslF345X03/doc4.xml…